These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23788391)

  • 21. Patent foramen ovale and cryptogenic stroke.
    Wood WC; Switchenko JM
    N Engl J Med; 2013 Jul; 369(1):88. PubMed ID: 23822783
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events.
    Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A
    Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis.
    Katsanos AH; Spence JD; Bogiatzi C; Parissis J; Giannopoulos S; Frogoudaki A; Safouris A; Voumvourakis K; Tsivgoulis G
    Stroke; 2014 Nov; 45(11):3352-9. PubMed ID: 25293664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The paradox of paradoxical embolism and recurrent stroke.
    Abou-Chebl A
    JACC Cardiovasc Interv; 2014 Aug; 7(8):921-2. PubMed ID: 25147038
    [No Abstract]   [Full Text] [Related]  

  • 25. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt.
    Weimar C; Holle DN; Benemann J; Schmid E; Schminke U; Haberl RL; Diener HC; Goertler M;
    Cerebrovasc Dis; 2009; 28(4):349-56. PubMed ID: 19628936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patent foramen ovale, transient ischemic attack and Kounis syndrome.
    Soufras GD; Kounis NG
    Int J Cardiol; 2014 Mar; 172(2):e303. PubMed ID: 24461972
    [No Abstract]   [Full Text] [Related]  

  • 28. Implantable devices for the closure of patent foramen ovale in adults: an Italian rapid health technology assessment.
    Migliore A; Jefferson T; Cerbo M; Abraha I; Montedori A
    Expert Rev Med Devices; 2014 Mar; 11(2):151-61. PubMed ID: 24506299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second device for a patent foramen ovale: life saver and psychotherapy.
    Meier B
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):151-2. PubMed ID: 20578221
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the armamentarium for effective PFO closure.
    Jumean M; Kimmelstiel C
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1268-9. PubMed ID: 25999279
    [No Abstract]   [Full Text] [Related]  

  • 34. Paradoxical embolism through the patent foramen ovale--the elderly is where the money is.
    Meier B
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):971-2. PubMed ID: 19021283
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrent embolic events after PFO closure: how often and why?
    Moussa ID
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):547-8. PubMed ID: 24078416
    [No Abstract]   [Full Text] [Related]  

  • 36. Patent foramen ovale: when is intervention warranted?
    Landzberg MJ; Khairy P
    Can J Cardiol; 2013 Jul; 29(7):890-2. PubMed ID: 23790552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do the right thing.
    Bartleson JD
    Neurology; 2005 Aug; 65(3):341. PubMed ID: 16097078
    [No Abstract]   [Full Text] [Related]  

  • 39. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials.
    Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR
    Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
    Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.